Apr 1982: Joined Taito Pfizer Inc. (now Pfizer Japan Inc.) Apr 1994: Product Manager, Antifungal Agents Group, Pharmaceutical Marketing Department, same company Dec 1996: General Manager, Clinical Development Department (Infectious Disease Agents), Clinical Development Division, R&D Headquarters, same company May 2000: General Manager, Development and Regulatory Affairs Division, Senior Manager, same company Mar 2004: Seconded to Pfizer Inc. (La Jolla, USA) as Global Regulatory Leader Sep 2008: Executive Officer and General Manager, Corporate Planning Division, Pfizer Japan Inc. Mar 2009: Executive Officer, Head of Corporate Affairs and Quality Assurance, and Chief Manufacturing and Marketing Officer, Pfizer Japan Inc. Dec 2009: Director and Executive Officer, Head of Established Products Business Unit, Pfizer Japan Inc. Apr 2013: Director and Executive Officer, Vice President for Asia Pacific Regional Strategy, Established Products Business, Pfizer Japan Inc. (resigned Dec 2013) Dec 2013: President, SBI Biotech Co., Ltd. (resigned Sep 2014) Apr 2016: CEO and President, Teva Pharmaceutical Japan Co., Ltd. (now T's Pharma Inc.) Apr 2017: CEO and President, Takeda Teva Pharmaceutical Co., Ltd. (now T's Pharmaceutical Co., Ltd.) Oct 2021: Representative Director, President and CEO, Takeda Teva Pharma Co., Ltd. (now T's Pharma Inc.) (resigned Apr 2023) Oct 2021: Representative Director, President and CEO, Takeda Teva Pharmaceutical Co., Ltd. (now T's Pharmaceutical Co., Ltd.) (resigned Apr 2023) Jul 2023: Joined the Company Aug 2023: Director and Vice President, in charge of Management Strategy, and General Manager, Administration Division Jan 2024: Representative Director and Vice President, in charge of Management Strategy, and General Manager, Administration Division Aug 2024: Representative Director and President Jan 2025: Representative Director, President and CEO (current)

Apr 1985: Joined the Company Jun 2001: Section Manager, Raw Materials Department, Active Pharmaceutical Ingredients Division Jun 2006: General Manager, Medical Products Department, Pharmaceutical Division; Deputy General Manager, Raw Materials Department, API Division Apr 2009: General Manager, Contract Development Promotion Department, Pharmaceutical Division Jun 2010: General Manager, Raw Materials Department, API Division Jun 2014: General Manager, Medical Products Department, Pharmaceutical Division Aug 2016: Executive Officer, Deputy Head of Pharmaceutical Division and General Manager, Medical Products Department Aug 2018: Director and Executive Officer, General Manager, Sales Division and Head of Pharmaceutical Division Jun 2022: Director and Managing Executive Officer, General Manager, Sales Division and Head of Pharmaceutical Division Aug 2025: Director and Managing Executive Officer, General Manager, Sales Division, Head of Pharmaceutical Division and General Manager, Tokyo Branch (current)

Apr 1986: Joined Daito Koeki Co., Ltd. (now Daito Co., Ltd.) Aug 2016: Executive Officer and General Manager, Corporate Planning Office, the Company Aug 2017: Executive Officer and Head of API Division, the Company Aug 2018: Director, Daiwa Pharmaceutical Co., Ltd. (now Daito Co., Ltd.); Director, Qianhui Pharmaceutical (Anhui) Co., Ltd. Jun 2019: Director, Felsen Pharma Co., Ltd. (current) Aug 2021: Managing Executive Officer and Head of API Division, and General Manager, Tokyo Branch, the Company Aug 2025: Managing Executive Officer and Head of Quality Assurance Division, the Company Oct 2025: Director, Dadong Pharmaceutical (China) Co., Ltd. (current) Aug 2026: Director and Managing Executive Officer, Head of Quality Assurance Division, the Company (current)

Apr 2012: Joined The Bank of Tokyo-Mitsubishi UFJ, Ltd. (now MUFG Bank, Ltd.) Oct 2018: Assistant Vice President, Asian Corporate Banking, MUFG Union Bank, USA (now Eastern U.S. Corporate Banking Division) Aug 2021: Assistant Manager, Human Resources Department, MUFG Bank, Ltd. (studied abroad at Harvard Business School) Jun 2023: Joined Daiwa Pharmaceutical Co., Ltd. (now Daito Co., Ltd.) Jan 2024: Executive Officer, Corporate Planning, assigned to the President's Office, Daiwa Pharmaceutical Co., Ltd. Aug 2024: Joined the Company Sep 2024: Chief Financial Officer (CFO), the Company Aug 2025: Executive Officer and CFO, the Company Aug 2025: Auditor, Dadong Pharmaceutical (China) Co., Ltd. (current) Aug 2026: Director and Executive Officer, CFO, the Company (current)

Apr 1985: Joined Takeda Pharmaceutical Company Limited Apr 2008: Director, CMC Research Center, Pharmaceutical Research Laboratories, Pharmaceutical Division, same company Apr 2010: General Manager, Production Management Department, Pharmaceutical Division, same company Apr 2012: General Manager, Pharmaceutical Planning Department, Pharmaceutical Division, same company Jul 2013: Plant Manager, Hikari Plant, Pharmaceutical Division, same company Apr 2015: Plant Manager, Hikari Plant, Global Pharmaceutical Supply, Japan and Asia, same company (resigned Mar 2018) Apr 2018: President and Representative Director, Takeda Healthcare Co., Ltd. (now Alinamin Pharmatec Co., Ltd.) (resigned Oct 2022) Nov 2022: Joined the Company Sep 2023: Executive Officer and Deputy Head of Production Division, the Company Jan 2024: Executive Officer, Head of Production Division, and Head of Environment and Safety Office, the Company Jun 2024: Executive Officer, Head of Production Division, General Manager, Formulation Manufacturing Department, and Head of Environment and Safety Office, the Company Aug 2024: Director and Executive Officer, Head of Production Division, General Manager, Formulation Manufacturing Department, and Head of Environment and Safety Office, the Company Aug 2025: Director and Managing Executive Officer, Head of Production Division, General Manager, Formulation Manufacturing Department, and Head of Environment and Safety Office, the Company Jun 2026: Director and Managing Executive Officer, Head of Production Division, and Head of Environment and Safety Office, the Company (current)

Apr 1980: Joined Daijun Hospital, Social Medical Corporation Koujunkai Aug 1996: Joined Hokuriku Institute of Preventive Medicine, General Incorporated Foundation Oct 2010: Occupational Health Counselor and Mental Health Promotion Officer, Toyama Occupational Health Support Center (current) Dec 2020: Representative, Mind Plus Toyama (current) Aug 2022: Director, the Company (current)

Apr 1983: Joined Taito Pfizer Inc. (now Pfizer Japan Inc.) Mar 2005: General Manager, Cardiovascular Sales Department, West Japan Sales Division, same company May 2006: General Manager, Corporate Planning Department, Office of the President, the Company Dec 2008: Branch Manager, West Tokyo Pharmaceutical Branch, Pfizer Japan Inc. Dec 2013: Branch Manager, IM Tohoku Pharmaceutical Branch, Pfizer Japan Inc. Apr 2018: Advisor, Vitalnet Inc. Jun 2018: President and Representative Director, Lead Specialties Inc. Jul 2018: Executive Officer and Deputy Head of Sales, Specialty Care Department, and in charge of Women's Empowerment, Vitalnet Inc. Jun 2021: President and Representative Director, Ayumi Pharmaceutical Corporation Jun 2024: Resigned from Ayumi Pharmaceutical Corporation Aug 2026: Director, the Company (current)

Apr 1991: Registered as attorney-at-law (Toyama Bar Association) Jun 2008: Outside Corporate Auditor, Richell Corporation (current) Aug 2012: Corporate Auditor, the Company Aug 2015: Director (Audit and Supervisory Committee Member), the Company (current)

Apr 2006: Joined Gosyokai Medical Foundation (Specified Medical Corporation) Jul 2009: Managing Director, same foundation Feb 2010: President, same foundation (current) Aug 2017: Director (Audit and Supervisory Committee Member), the Company (current) Jul 2025: President, Armstrong Aoba Kindergarten, School Corporation (current)

Apr 1993: Joined The Tokyo Bank, Ltd. (now MUFG Bank, Ltd.) Feb 2002: Europe Desk, Foreign Exchange and Funding Department, same bank Apr 2010: Senior Analyst, Market Operations Department, same bank May 2012: Chief Analyst, Market Planning Department, same bank Apr 2022: Associate Professor, Faculty of Commerce, Takachiho University Apr 2024: Professor, Faculty of Commerce, Takachiho University (current) Aug 2025: Director (Audit and Supervisory Committee Member), the Company (current)